Showing results (101-110 of 131) with videos related to
Sort By:
Pageof 14
Pharmacogenomics|July 18, 2013
OCT1 genetic variants influence the pharmacokinetics of morphine in childrenTsuyoshi Fukuda, Vidya Chidambaran, Tomoyuki Mizuno, et al.Transplantation|April 12, 2012
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantationDavid K Hooper, Tsuyoshi Fukuda, Rhonda Gardiner, et al.Journal of Opioid Management|September 4, 2012
Morphine clearance in children: does race or genetics matter?Senthilkumar Sadhasivam, Elke H J Krekels, Vidya Chidambaran, et al.Rinsho Byori. the Japanese Journal of Clinical Pathology|April 20, 2007
Determination of single nucleotide polymorphisms in N-acetyltransferase2 gene using an electrochemical DNA chip and an automated DNA detection systemNaoko Nakamura, Keiko Ito, Sadato Hongo, et al.Journal of Clinical Psychopharmacology|September 17, 2008
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipranMasataka Wakeno, Masaki Kato, Gaku Okugawa, et al.The Journal of Antimicrobial Chemotherapy|September 3, 2016
Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysisKevin J Downes, Min Dong, Tsuyoshi Fukuda, et al.Diabetes, Obesity & Metabolism|October 10, 2023
Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusionJennifer Leohr, Mary Anne Dellva, Elizabeth LaBell, et al.Neuropsychobiology|July 29, 2006
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patientsMasaki Kato, Tsuyoshi Fukuda, Masataka Wakeno, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 17, 2008
Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorderMasaki Kato, Tsuyoshi Fukuda, Masataka Wakeno, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 5, 2007
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorderMasaki Kato, Tsuyoshi Fukuda, Alessandro Serretti, et al.Pageof 14